CA Patent

CA3095341C — Levodopa fractionated dose composition and use

Assigned to AVION PHARMACEUTICALS LLC · Expires 2025-11-25 · 0y expired

What this patent protects

There is provided a convenient new treatment of Parkinson disease by a frequent administration of optimal levodopa doses mimicking a continuous intravenous or infusion treatment, thus mitigating motor complications; and a new carbidopa/levodopa pharmaceutical unit form providing …

USPTO Abstract

There is provided a convenient new treatment of Parkinson disease by a frequent administration of optimal levodopa doses mimicking a continuous intravenous or infusion treatment, thus mitigating motor complications; and a new carbidopa/levodopa pharmaceutical unit form providing said new treatment.

Drugs covered by this patent

Patent Metadata

Patent number
CA3095341C
Jurisdiction
CA
Classification
—
Expires
2025-11-25
Drug substance claim
No
Drug product claim
No
Assignee
AVION PHARMACEUTICALS LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.